Höglinger G - Search Results

1

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.

Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K, Palma JA, Meissner WG, Krismer F, Berg D, Cortelli P, Freeman R, Halliday G, Höglinger G, Lang A, Ling H, Litvan I, Low P, Miki Y, Panicker J, Pellecchia MT, Quinn N, Sakakibara R, Stamelou M, Tolosa E, Tsuji S, Warner T, Poewe W, Kaufmann H. Wenning GK, et al. Among authors: hoglinger g. Mov Disord. 2022 Jun;37(6):1131-1148. doi: 10.1002/mds.29005. Epub 2022 Apr 21. Mov Disord. 2022. PMID: 35445419 Free PMC article. Review.

2

Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial.

Stamelou M, Reuss A, Pilatus U, Magerkurth J, Niklowitz P, Eggert KM, Krisp A, Menke T, Schade-Brittinger C, Oertel WH, Höglinger GU. Stamelou M, et al. Mov Disord. 2008 May 15;23(7):942-949. doi: 10.1002/mds.22023. Mov Disord. 2008. PMID: 18464278 Clinical Trial.

3

In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.

Stamelou M, Pilatus U, Reuss A, Magerkurth J, Eggert KM, Knake S, Ruberg M, Schade-Brittinger C, Oertel WH, Höglinger GU. Stamelou M, et al. J Cereb Blood Flow Metab. 2009 Apr;29(4):861-70. doi: 10.1038/jcbfm.2009.2. Epub 2009 Feb 4. J Cereb Blood Flow Metab. 2009. PMID: 19190655

4

Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.

Stamelou M, Matusch A, Elmenhorst D, Hurlemann R, Eggert KM, Zilles K, Oertel WH, Höglinger GU, Bauer A. Stamelou M, et al. Mov Disord. 2009 Jun 15;24(8):1170-5. doi: 10.1002/mds.22533. Mov Disord. 2009. PMID: 19353726

5

In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS.

Knake S, Belke M, Menzler K, Pilatus U, Eggert KM, Oertel WH, Stamelou M, Höglinger GU. Knake S, et al. Mov Disord. 2010 Jul 15;25(9):1232-8. doi: 10.1002/mds.23054. Mov Disord. 2010. PMID: 20222139

6

Rational therapeutic approaches to progressive supranuclear palsy.

Stamelou M, de Silva R, Arias-Carrión O, Boura E, Höllerhage M, Oertel WH, Müller U, Höglinger GU. Stamelou M, et al. Brain. 2010 Jun;133(Pt 6):1578-90. doi: 10.1093/brain/awq115. Epub 2010 May 14. Brain. 2010. PMID: 20472654 Review.

7

Magnetic resonance imaging in progressive supranuclear palsy.

Stamelou M, Knake S, Oertel WH, Höglinger GU. Stamelou M, et al. Among authors: hoglinger gu. J Neurol. 2011 Apr;258(4):549-58. doi: 10.1007/s00415-010-5865-0. Epub 2010 Dec 22. J Neurol. 2011. PMID: 21181185

8

Hypodipsia discriminates progressive supranuclear palsy from other parkinsonian syndromes.

Stamelou M, Christ H, Reuss A, Oertel W, Höglinger G. Stamelou M, et al. Among authors: hoglinger g. Mov Disord. 2011 Apr;26(5):901-5. doi: 10.1002/mds.23587. Epub 2011 Mar 7. Mov Disord. 2011. PMID: 21384428

9

Cost-of-illness in multiple system atrophy and progressive supranuclear palsy.

Winter Y, Stamelou M, Cabanel N, Sixel-Döring F, Eggert K, Höglinger GU, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R, Spottke AE. Winter Y, et al. J Neurol. 2011 Oct;258(10):1827-34. doi: 10.1007/s00415-011-6028-7. Epub 2011 Apr 10. J Neurol. 2011. PMID: 21479850

10

Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.

Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Höglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R. Winter Y, et al. Neurodegener Dis. 2011;8(6):438-46. doi: 10.1159/000325829. Epub 2011 May 12. Neurodegener Dis. 2011. PMID: 21576919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page